The Nutshell

» disease/medicine

Daily News Roundup

Most Recent

image: Pilot Study Treats Infants for Autism

Pilot Study Treats Infants for Autism

By | September 11, 2014

A preliminary trial finds that teaching parents certain therapeutic interactions for babies showing early signs of autism may improve the infants’ future social development.

1 Comment

image: Enterovirus Spreads Among US Kids

Enterovirus Spreads Among US Kids

By | September 10, 2014

A previously rare respiratory virus is landing hundreds of children in hospitals.

0 Comments

image: Ebola’s Exponential Increase in Liberia

Ebola’s Exponential Increase in Liberia

By | September 10, 2014

World Health Organization officials say intervention efforts must be scaled up at least three-fold.

1 Comment

image: Ebola Vaccine Protects Macaques

Ebola Vaccine Protects Macaques

By | September 9, 2014

Human trials are now underway.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

image: Social Data for Ebola Surveillance

Social Data for Ebola Surveillance

By | August 26, 2014

Algorithms that map social media posts and mobile phone data can help researchers track epidemics.

0 Comments

image: Marburg Drug Shows Promise

Marburg Drug Shows Promise

By | August 22, 2014

Monkeys infected with lethal doses of Marburg virus were rescued by an experimental siRNA-based therapeutic, a study shows.

0 Comments

image: DARPA Challenge to Predict Chikungunya Spread

DARPA Challenge to Predict Chikungunya Spread

By | August 19, 2014

Contest aims to identify models that accurately forecast outbreaks.

0 Comments

image: Chikungunya Vaccine Clears Phase 1

Chikungunya Vaccine Clears Phase 1

By | August 18, 2014

Early-stage clinical trial yields promising results. 

0 Comments

image: Biotech Terminates IPO

Biotech Terminates IPO

By | August 15, 2014

The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech